Global Stem Cell and Advanced Technologies Market

Date: November 22, 2009
Pages: 229
Price:
US$ 5,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G431AE9D788EN
Leaflet:

Download PDF Leaflet

Global Stem Cell and Advanced Technologies Market
The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth.

The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the global stem cell market; and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. This research report will help stakeholders gain a better understanding of product pricing and regulatory framework governing the dynamics of the stem cell market. The key players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron.

Market Estimates and Forecasts

The report categorizes the global stem cell market as follows:

• Stem Cell Products (adult stem cell, human embryonic stem cell, and other stem cell types)

• Stem Cell Services (stem cell banking, stem cell acquisition and testing, drug discovery and target identification, isolation/characterization services, and molecular biology )

• Stem Cell Technologies (stem cell acquisition, stem cell production, cryopreservation, and expansion and subculture)

• Stem Cell Applications (regenerative medicine – neurological disorders, orthopedics, cancer, hematological disorders, myocardial infarction and cardiovascular diseases, injuries, diabetes, liver disorder, incontinence, and drug development)

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides more than 35 company profiles for each of its sub-segments.

What makes our reports unique?

- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.

- We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.

- We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

- Comprehensive market analysis for the following sectors:

Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

- Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

Executive summary

MARKET OVERVIEW

Stem cell market dynamics

OPPORTUNITIES

Stem cells product market

OPPORTUNITIES

Stem cells technology market
Stem cells services market
Stem cells applications market
Geographic analysis
Competitive landscape

1. INTRODUCTION

1.1. KEY TAKE-AWAYS
1.2. REPORT DESCRIPTION
1.3. Research METHODOLOGY
1.4. STAKEHOLDERS

2. SUMMARY

3. MARKET OVERVIEW

3.1. Defining the stem cell market
3.2. Factors influencing the stem cells market
3.3. Stem cell market inhibitors
3.4. Regenerative medicine dominates stem cell applications
3.5. FACTORS INFLUENCING THE STEM CELLS MARKET
  3.5.1. U.S. lifts ban on funding
  3.5.2. Guidelines for responsible stem cells research
  3.5.3. European national policies and legal issues
  3.5.4. E.U. funding for stem cells research
  3.5.5. Asia Pacific
3.6. Stem cell patent analysis

4. STEM CELL MARKET DYNAMICS

4.1. Drivers
  4.1.1. Potential of stem cells in regenerative medicine
  4.1.2. Key to anti-ageing and prolonging life
  4.1.3. Increasing R&D INVESTMENTS in adult stem cell research
  4.1.4. EASE of administration
  4.1.5. Reduced risk of tissue rejection in transplants
  4.1.6. Federal funding for stem cell research
4.2. Restraints
  4.2.1. safety issues
  4.2.2. Ethical issueS
  4.2.3. Insurance issues
4.3. Opportunities
  4.3.1. technological innovations
  4.3.2. Emerging application as a drug discovery tool
  4.3.3. other promising applications

5. GLOBAL STEM CELLS PRODUCT MARKET

5.1. potency-based Stem cell classification
5.2. Adult stem cells
  5.2.1. Drivers
    5.2.1.1. Applications in cancer and chronic disease treatment
    5.2.1.2. Availability of adequate safety & efficacy evidence
    5.2.1.3. Technology innovations
    5.2.1.4. Lower costs & no ethical issues
  5.2.2. Restraints & Opportunities
    5.2.2.1. Lower therapeutic potential
    5.2.2.2. Need for minimising intervention
  5.2.3. Hematopoietic Stem Cells
    5.2.3.1. Drivers & Restraints
      5.2.3.1.1. Wide range of applications
      5.2.3.1.2. Technology developments
      5.2.3.1.3. Underused treatment, ineffective GvHD management
  5.2.4. Mesenchymal stem cells
    5.2.4.1. Drivers
      5.2.4.1.1. Huge potential of MSCs
      5.2.4.1.2. Advantageous cell type for allogenic transplantation
    5.2.4.2. Restraints & Opportunities
      5.2.4.2.1. Low number of mesenchymal stem cells in bone marrow
    5.2.4.3. Potential applications of MSC therapy
5.3. Embryonic stem cells
  5.3.1. Drivers & REStraints
    5.3.1.1. Immense potential due to pluripotent nature
    5.3.1.2. Ban on federal funding lifted
    5.3.1.3. Ethical issues and inadequate safety data
  5.3.2. Umbilical cord stem cells
  5.3.3. Neuronal stem cells
  5.3.4. Dental stem cells
  5.3.5. Other novel cell types

6. STEM CELLS TECHNOLOGY MARKET

6.1. Stem cell production
  6.1.1. Somatic nuclear transfer / Therapeutic cloning
  6.1.2. IVF (In vitro fertilization)
  6.1.3. Isolation & Cell culture
6.2. Expansion & Sub-culture
6.3. Stem cell acquisition
  6.3.1. Bone marrow harvest
  6.3.2. Apheresis
  6.3.3. Umbilical cord blood stem cells acquisition
6.4. Cryopreservation & storage

7. GLOBAL STEM CELLS SERVICES MARKET

7.1. Stem cell banking
  7.1.1. Ethical issues on stem cell banking
7.2. Stem cell acquisition & testing
7.3. Characterization services
  7.3.1. HLA typing services
  7.3.2. Stem cell custom services
  7.3.3. Stem cell custom antibody services
7.4. Molecular biology
7.5. Drug screening & target validation

8. GLOBAL STEM CELLS APPLICATIONS MARKET

8.1. Regenerative medicine
  8.1.1. Drivers & Restraints
    8.1.1.1. Simple and cost-effective production method
    8.1.1.2. Public & political support
    8.1.1.3. High cost of treatment and low reimbursements
  8.1.2. Neurological disorders
    8.1.2.1. Alzheimer’s disease
    8.1.2.2. Parkinson’s disease
    8.1.2.3. Multiple sclerosis
    8.1.2.4. Other diseases
  8.1.3. Myocardial Infarction & cardiovascular diseases
  8.1.4. Cancer
    8.1.4.1. Breast cancer
    8.1.4.2. Multiple myeloma
    8.1.4.3. Other cancers
  8.1.5. Injuries
  8.1.6. Incontinence
  8.1.7. Diabetes
  8.1.8. Orthopedics
  8.1.9. Liver disorders
  8.1.10. Hematological disorders
    8.1.10.1. Other applications
      8.1.10.1.1. Limb ischemia
      8.1.10.1.2. Systemic lupus
8.2. Drug Discovery & Development

9. GEOGRAPHIC ANALYSIS

9.1. North America
9.2. Europe
9.3. Asia
9.4. ROW

10. COMPETITIVE LANDSCAPE

11. COMPANY PROFILES

11.1. Advanced Cell Technology Inc
11.2. Aldagen
11.3. Angel Biotechnology
11.4. Angioblast Systems Inc
11.5. Aastrom Biosciences Inc
11.6. Athersys
11.7. Bioheart Inc
11.8. Brainstorm Cell Therapeutics
11.9. California Stem Cell
11.10. Celgene Corporation
11.11. Cellartis AB
11.12. Cellerant Therapeutics
11.13. Cellular Dynamics International, Inc
11.14. Cellular Engineering Technologies
11.15. CordLife Ltd
11.16. Cytori Therapeutics Inc
11.17. ES Cell International
11.18. Gamida Cell Ltd
11.19. Genzyme Corporation
11.20. Geron Corporation Inc
11.21. Global Stem Inc
11.22. Intercytex
11.23. Medistem Inc
11.24. Mesoblast Ltd
11.25. MultiCell Technologies, Inc
11.26. Neostem
11.27. Novocell Inc
11.28. NeuralStem Biopharmaceuticals, Ltd.
11.29. Opexa Therapeutics
11.30. Osiris Therapeutics, Inc
11.31. Plureon Corp
11.32. Pluristem Therapeutics
11.33. ReNeuron, Inc
11.34. StemCells, Inc
11.35. StemLifeLine
11.36. t2cure Gmbh
11.37. TheraVitae
11.38. Thermo Fisher Scientific Inc
11.39. Thermogenesis Corporation
11.40. VetCell Bioscience Ltd

APPENDIX

U.S. Government policies & guidelines FOR STEM CELL RESEARCH
Patents for united states
Patents for europe
Patents for Japan

LIST OF TABLES

SUMMARY TABLE GLOBAL STEM CELL MARKET BY PRODUCT, SERVICES AND TECHNOLOGY 2009-2014 ($ MILLIONS)
Table 1 Global stem cell market by product 2007-2014 ($ Millions)
Table 2 Global adult stem cell market by product 2007-2014 ($ Millions)
Table 3 Global other novel cell types market by product 2007-2014 ($ Millions)
Table 4 Global stem cell technology market 2007-2014 ($ Millions)
Table 5 Global stem cell production market by product 2007-2014 ($ Millions)
Table 6 Global stem cell acquisition market by product 2007-2014 ($ Millions)
Table 7 Global stem cell services market 2007-2014 ($ Millions)
Table 8 Global characterization services market 2007-2014 ($ Millions)
Table 9 GLOBAL STEM CELL APPLICATIONS MARKET BY PRODUCT 2007-2014 ($ MILLIONS)
Table 10 Global stem cell applications market by geography 2007-2014 ($ Millions)
Table 11 Global regenerative medicine market by product 2007-2014 ($ Millions)
Table 12 Global regenerative medicine market by geography 2007-2014 ($ Millions)
Table 13 Global neurological disorders market by geography 2007-2014 ($ Millions)
Table 14 Global Myocardial Infarction & cardiovascular diseases market by geography 2007-2014 ($ Millions)
Table 15 Global stem cell therapy market for cancer by geography 2007-2014 ($ Millions)
Table 16 Global stem cell therapy market for Injuries by product 2007-2014 ($ Millions)
Table 17 Global stem cell therapy market for Injuries by geography 2007-2014 ($ Millions)
Table 18 Global stem cell therapy market for Incontinence by geography 2007-2014 ($ Millions)
Table 19 Global stem cell therapy market for Diabetes by geography 2007-2014 ($ Millions)
Table 20 Global stem cell therapy market for Orthopedics by geography 2007-2014 ($ Millions)
Table 21 Global stem cell therapy market for Liver disorders by geography 2007-2014 ($ Millions)
Table 22 Global stem cell therapy market for Hematological disorders by geography 2007-2014 ($ Millions)
Table 23 Global Other regenerative medicines market by geography 2007-2014 ($ Millions)
Table 24 Global Drug Discovery & Development market by geography 2007-2014 ($ Millions)
Table 25 New product, technology, service launch IN THE STEM CELLS MARKET (2008-2009)
Table 26 agreements and collaborations IN THE STEM CELLS MARKET (2008-2009)
Table 27 mergers and acquisition IN THE STEM CELLS MARKET (2008-2009)

LIST OF FIGURES

Figure 1 STEM CELL MARKET SEGMENTATION
Figure 2 FACTORS Driving STEM CELL MARKET GROWTH
Figure 3 FACTORS INHIBITING STEM CELL MARKET GROWTH
Figure 4 Stem cell application market dynamics
Figure 5 RELATIVE IMPORTANCE OF FACTORS AFFECTING STEM CELL MARKET
Figure 6 NIH funding for stem cell research
Figure 7 patent analysis by geography 2006 to 2008
Figure 8 Patent analysis by segment 2006 to 2008
Figure 9 Patent analysis by competitors
Figure 10 Major market growth factors
Figure 11 Stem cell classification on the basis of potency
Figure 12 Stem cell technologies
Figure 13 Prominent focus areas in regenerative medicine
Figure 14 Stem cell transplants types
Figure 15 global Stem cells market by geography ($billion)
Figure 16 North American Stem cells market
Figure 17 european Stem cells market
Figure 18 asian Stem cells market
Figure 19 row Stem cells market
Figure 20 Major segments IN THE global stem cell market (2008-2009)
figure 21 collaborations IN THE global stem cell market (2008-2009)

Skip to top


Ask Your Question

Global Stem Cell and Advanced Technologies Market
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: